Impact of sex on cardiac remodeling and long‐term outcomes, following mitral valve replacement

2020 ◽  
Author(s):  
Ryaan EL‐Andari ◽  
Sabin J. Bozso ◽  
Jimmy J.H Kang ◽  
Dana Boe ◽  
Nicholas M. Fialka ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Cardiac Remodeling ◽  
Long Term Outcomes

Mitral Valve Replacement Using Mechanical Prostheses in Children: Early and Long-Term Outcomes

2012 ◽  
Vol 33 (4) ◽  
pp. 639-645 ◽  
Author(s):  
Hyung-Tae Sim ◽  
Seung-Cheol Lee ◽  
Hong Ju Shin ◽  
Jeong-Jun Park ◽  
Tae-Jin Yun ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Long Term Outcomes ◽  
Mechanical Prostheses

scholarly journals Bioprosthetic mitral valve replacement in patients aged 65 years or younger: long-term outcomes with the Carpentier–Edwards PERIMOUNT pericardial valve†

2018 ◽  
Vol 54 (2) ◽  
pp. 302-309 ◽  
Author(s):  
Thierry Bourguignon ◽  
Fabien Espitalier ◽  
Clémence Pantaleon ◽  
Emmanuelle Vermes ◽  
Jean Marc El-Arid ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Long Term Outcomes ◽  
Bioprosthetic Mitral Valve

scholarly journals Long-term outcomes after reoperation for mitral paravalvular leaks: a single-centre experience

2020 ◽  
Author(s):  
Shin Yajima ◽  
Satsuki Fukushima ◽  
Kizuku Yamashita ◽  
Yusuke Shimahara ◽  
Naoki Tadokoro ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Prosthetic Valve Endocarditis ◽  
Paravalvular Leak ◽  
Class Iii ◽  
Long Term Outcomes ◽  
Low Cardiac Output Syndrome

Abstract OBJECTIVES We aimed to analyse the pathology of paravalvular leak (PVL), and determine the long-term outcomes of redo mitral valve replacement and risk factors of all-cause mortality. METHODS Seventy-nine patients (mean age 70 ± 9 years; 54 female, 68%) who underwent redo mitral valve replacement for mitral PVL between January 2000 and May 2019 were retrospectively reviewed. Indications for PVL intervention were haemolytic anaemia (57/79, 72%), New York Heart Association class III/IV congestive heart failure (56/79, 71%) and prosthetic valve endocarditis with PVL (2/79, 3%). RESULTS PVL most commonly occurred at lateral sectors (42/79, 55%). Early mortality occurred in 2 patients (3%) due to low cardiac output syndrome. Two patients (3%) had residual PVL at discharge. Sixteen patients (23%) developed late PVL (mean follow-up, 3.4 ± 2.9 years), among whom 11 (69%) developed PVL at same area as that preoperatively. Additionally, 9 patients (56%) developed PVL at lateral sectors in late follow-up. At 1, 5 and 10 years, the survival rate was 93%, 72% and 45%; rate of freedom from cardiac death was 96%, 92% and 78%; and rate of freedom from PVL recurrence was 94%, 82% and 54%, respectively. Chronic kidney disease was the only risk factor in the multivariate analysis for mortality [P = 0.013; hazard ratio 4.0 (1.4–11.0)]. CONCLUSIONS Surgery for mitral PVL confers reasonable early and long-term outcomes. Greater attention to the anterolateral annulus may help prevent PVL.

scholarly journals IMMEDIATE AND LONG-TERM OUTCOMES AFTER BIOPROSTHETIC MITRAL VALVE REPLACEMENT WITH THE PRESERVATION OF THE SUBVALVULAR APPARATUS

2018 ◽  
Vol 7 (2) ◽  
pp. 38-49
Author(s):  
Yu. N. Odarenko ◽  
N. V. Rutkovskaya ◽  
S. G. Kokorin ◽  
A. N. Stasev ◽  
L. S. Barbarash
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Invasive Monitoring ◽  
Central Hemodynamics ◽  
Long Term Outcomes ◽  
Group 2 ◽  
Bioprosthetic Mitral Valve ◽  
Group 1

Aim. To assess the immediate and long-term outcomes after bioprosthetic mitral valve replacement with the preservation of the subvalvular apparatus. Methods. 304 patients who underwent primary bioprosthetic mitral valve replacement in the period from 2001 to 2009 were included in the study. Patients were enrolled into two groups with either preserved subvalvular structures (Group 1. n = 142, 47%) or resected structures (Group 2, n = 162) during bioprosthetic mitral valve replacement. For the unbiased assessment of the efficiency of valve-preserving approach, randomly selected patients from Group 1 (n = 75) and Group 2 (n = 40) underwent preoperative and postoperative invasive monitoring of the central hemodynamics using the Swan-Ganz thermodilution catheter. Results In-hospital mortality was 1.4% (n = 2) in Group 1 and 4.3% in Group 2. The most common cause of death was acute left ventricular failure. We found that the preservation of subvalvular structures allows ensuring the optimal linear and volumetric echocardiography parameters in the immediate postoperative period, despite the hemodynamic profile of the defect. However, the positive effects were more pronounced in patients with more severe mitral regurgitation. Patients with preserved subvalvular structures had more durable surgical mitral valve replacement according to the echocardiographic findings in the long-term period. The invasive monitoring of central hemodynamics allowed determining that total subvalvular apparatus preservation was associated with more significant pressure decline in the pulmonary circulation (mean pulmonary arterial pressure and pulmonary capillary wedge pressure) and improved cardiac index and output. Posterior leaflet preservation was associated with less pronounced changes and patients who underwent routine mitral valve replacement had the worst intermediate outcomes. Conclusion The results of the presented study suggest that the preservation of subvalvular apparatus, unless otherwise indicated, is associated with improved immediate and long-term outcomes after mitral valve replacement. 

Analysis of Perioperative Parameters and Long-Term Outcomes of Patients with Isolated Mitral Valve Replacement

2016 ◽  
Vol 64 (S 01) ◽  
Author(s):  
B. Pfannmüller ◽  
M. Misfeld ◽  
F. Bakhtiary ◽  
P. Davierwala ◽  
J. Garbade ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Long Term Outcomes
Sign in / Sign up

Export Citation Format

Share Document